An observational study in Aortic Diseases, Aortic Dissection and Aortic Aneurysm, Thoracic, sponsored by Golden Jubilee National Hospital. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-15.
Sponsored by Golden Jubilee National Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Aortic Diseases with a site in United Kingdom — 4 open to participants now, 6 under way, none of them phase 3. Aortic Diseases · United Kingdom.
Among the 13 studies in Aortic Diseases with a site in United Kingdom, this one is one of 2 that started in 2023, is one of 8 observational ones, and was the 11th registered.
109 studies on the registry are indexed under Aortic Diseases; 44 are open to participants now.
Browse Aortic Diseases studies →4 of the 13 studies in Aortic Diseases with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Nottingham · Sites in United Kingdom
Ages 18+ · Healthy volunteers
Vascutek Ltd. · Sites in United Kingdom, United States, Austria and 2 more countries
Ages 18+
Barts & The London NHS Trust · Sites in United Kingdom
Ages 18+
The University of Texas Health Science Center, Houston · Sites in United Kingdom, United States, Australia and 3 more countries
Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 36 Aortic Diseases studies recruiting now, 28 (78%) set no upper age limit and 2 (6%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2023.
This study's enrollment of 1,662 is above the median of 186 across 62 observational studies indexed under Aortic Diseases.
Median enrollment 70 across the 5 interventional studies, 145 across the 8 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 13 have an industry lead sponsor. The 10 most frequent:
Golden Jubilee National Hospital is the lead sponsor of 30 studies on the registry; 4 are open to participants now.
Golden Jubilee National Hospital has 1 study filed under Aortic Diseases — fewer than ten, so there is no comparison to draw.
1 of the studies in Aortic Diseases with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07078383Vascutek Ltd.A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta | 2027-11 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Aortic Diseases with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aorta is the principal arterial vessel arising from the left heart that transfers blood to the body. Certain genetic and familial disease processes are known to weaken the aortic wall resulting in dilation and potential rupture. These aortic complications carry high mortality (>25%) and current management is orientated towards early detection and preventive treatment. Aortic dilation can also result in aortic valve dysfunction leading to heart failure. The estimated UK incidence of aortic disease per year is around 10 per 100,000 individuals, with 2000 people per year dying from aortic complications.
The 2017-2020 National Adult Cardiac Surgery Audit report identified the number of people receiving surgery for aortic dissection in Scotland is per population proportionately lower compared to England (4.6 per million per year in Scotland vs. 6.6 per million per year in England). The reasons for this are unclear but may relate to the prevalence of aortic disease or a large geographic distribution with compromised access to specialized centres.
Currently surgery is recommended when the aortic diameter exceeds a certain threshold. There are several types of effective surgical procedures, but there is still limited information on their long-term outcomes and the advantage of one procedure over another.
The aims of the project are firstly to determine the clinical outcomes of the surgical procedures that are currently employed in Scotland to treat proximal aortic disease and secondly to describe the prevalence and distribution of proximal aortic disease within the Scottish population. The project will be hosted by the Golden Jubilee Research Institute. Contemporary and retrospective data will be collected from all the Scottish Cardiothoracic Surgery units which are based in Glasgow, Edinburgh and Aberdeen.
This will be the first study to analyse surgical outcomes for ascending aortic disease in Scotland, and the first to describe the epidemiology of aortic disease within the population. It is anticipated that the results will guide current surgical practise, and provide data to inform national service provision for the management of proximal aortic disease.
The study has two principal aims:
This study will be the first to look at outcomes from a nation-wide cohort of patients following surgery of the thoracic aorta in the UK. The investigators anticipate that results from this study will inform future aortic practice and guide decisions on intervention timing and type.
Information on the prevalence and geographic distribution of aortic disease within Scotland will guide resource allocation and service configuration to allow equity in access to treatment. By raising awareness among the medical professionals and the wider community, the study should lead to improved recognition and better outcomes for patients with aortic disease.
Data will be recorded in a contemporary and retrospective manner for two patient cohorts:
Non-surgical cohort - Adult patients who have a diagnosis of proximal aortopathy, but have not had surgery. This cohort will be obtained from three sources:
The three data collection sites will be the Golden Jubilee National Hospital in Glasgow, the Edinburgh Royal Infirmary and Aberdeen Royal Infirmary.
The surgical cohort sample size is expected to be around 1300 patients. The non-surgical cohort is difficult to estimate, but around 500 cases yearly are expected to be identified. The research project will be hosted by the NHS Golden Jubilee Research Department.
The principal investigator (George Gradinariu) will undertake this research project as part of an postgraduate research programme (MD degree) at the University of Glasgow under the supervision of Professor Mark Danton (Congenital Cardiac Surgeon with interest in proximal aortic surgery), Professor Alex McConnachie Professor of Biostatistics, University of Glasgow) and Professor Faisal Ahmed (Samson Gemmell Chair of Child Health, University of Glasgow)
Statistical analysis will be overseen and supervised by Professor McConnachie. Descriptive statistics will be applied. Survival data will be analysed using Kaplan-Meier. Multivariable survival and logistic regression models will be used to identify variables predicting the risk of adverse outcomes. Predictive modelling to estimate the risk of adverse outcomes based on aortic root dimension will be assessed using ROC analysis. In comparing survival by procedures propensity matching will be used to minimize confounding. Analysis will be performed using R statistical analysis software (R Foundation for Statistical Computing, Vienna, Austria).
Non-surgical cohort (Cross-sectional design) - Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources:
Surgical cohort
Inclusion Criteria:
Exclusion Criteria:
Non-surgical cohort
Inclusion Criteria:
Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen.
Procedure: Surgery on the proximal aorta (aortic root +/- ascending aorta)
- Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources: 1. Scottish national radiological database based on specific imaging codes 2. Regional genetic/inherited cardiac conditions services 3. Public Health Scotland via specific diagnostic ICD-10 codes.
Other: Patients diagnosed with thoracic aortopathy but not operated upon
Surgery involving replacing, repairing or reinforcing the proximal aorta (root and ascending aorta)
Radiological size criteria or Genetic mutations associated with aortopathies
Early survival following surgery of the proximal aorta
In-hospital or 30 days survival following surgery of the proximal aorta
Time frame: In-hospital or 30 days (whichever is longer)
Late survival following surgery of the proximal aorta
Long-term survival following surgery of the proximal aorta
Time frame: 5 years or latest available follow-up (whichever is longer)
Patient demographics and geographic distribution of thoracic aortopathy within the Scottish population
Identify the demographics (age, gender, relevant risk factors) and geographic distribution (area codes) of patients diagnosed with thoracic aortopathy within the Scottish population
Time frame: Cross-sectional analysis (2011-2021)
Cardiovascular reintervention
Reinterventions (surgical/endovascular) related to the aortic implant or unoperated aorta Reintervention on Aortic valve (native or prosthesis)
Time frame: 1 year or latest available follow-up (whichever is longer)
Specified adverse events following surgery
episodes of endocarditis, structural valve degeneration, thromboembolism, cerebral vascular accident, anticoagulant-related bleeding
Time frame: 1 year or latest available follow-up (whichever is longer)
Left ventricular ejection fraction (LVEF) following surgery
Long-term left ventricular ejection fraction (\>50% - good, 31-50% - moderate, 21-30% - poor, 20% or less -very poor) as measured by echocardiography or cardiac MRI after surgery
Time frame: 1 year or latest available follow-up (whichever is longer)
Aortic valve mean gradient and degree of regurgitation following surgery
Long-term aortic valve function as assessed by mean gradient (mmHg) and degree of regurgitation (mild/moderate/severe) in operated patients assessed by echocardiography or cardiac MRI
Time frame: 1 year or latest available follow-up (whichever is longer)
Genotypes and phenotypes prevalent in the Scottish population
Identify genotypes and phenotypes in the Scottish population and assess their prevalence
Time frame: Previous 5 years
Plan to share: No — To apply for further studies, beyond the current research, using the existing dataset, a research proposal submitted to the GJNH Research Department will be required. This will follow the established internal peer-review process established by the GJNH research department. If approved, a data request form will need to be submitted to the data custodian who will release the pseudo- anonymised data to the research applicant. If there is no request to extend the study then this data will be deleted.
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Aug 2025, 20 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Golden Jubilee National Hospital